GlucoTrack, Inc., a medical device company, designs, develops and markets noninvasive glucose monitoring devices for people with diabetes and prediabetes in Europe and Asia Pacific. The company is headquartered in Or Yehuda, Israel.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | -20,000 |
| EBITDA | $-16.74M |
| Operating Margin | 0.00% |
| Return on Equity | -527.00% |
| Return on Assets | -150.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.34 |
| Price-to-Book | 0.65 |
| Price-to-Sales (TTM) | 526.95 |
| EV/Revenue | 420.95 |
| EV/EBITDA | -1.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $6.26M |
| Float | $6.16M |
| % Insiders | 0.94% |
| % Institutions | 4.34% |
Volatility is currently expanding